Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

β-catenin Helices in the Cytoplasm of Sporadic and FAP Duodenal Adenomas

CARLOS A. RUBIO, ANN KAUFELDT, RAFAT KOHAN, MARIKO USHOIDA, ERIKA EZELIUS, SAN BJÖRK and JENNY LINDAHL
Anticancer Research March 2015, 35 (3) 1433-1436;
CARLOS A. RUBIO
Department of Pathology, Karolinska University Hospital, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Carlos.Rubio@ki.se
ANN KAUFELDT
Department of Pathology, Karolinska University Hospital, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
RAFAT KOHAN
Department of Pathology, Karolinska University Hospital, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARIKO USHOIDA
Department of Pathology, Karolinska University Hospital, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ERIKA EZELIUS
Department of Pathology, Karolinska University Hospital, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SAN BJÖRK
Department of Pathology, Karolinska University Hospital, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JENNY LINDAHL
Department of Pathology, Karolinska University Hospital, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background: Initiation and progression in conventional adenomas is triggered by deregulation of Wnt/β-catenin signaling. In the absence of Wnt signal (off-state), β-catenin prevents phosphorylation of glycogen synthase kinase (GSK)-3β leading to aberrant nuclear accumulation in human tumors. While investigating the nuclear expression of β-catenin in biopsies from duodenal adenomas, we observed a non-previously reported phenomenon, namely the presence of β-catenin cytoplasmic helices (coils). Materials and Methods: Sections from 39 biopsies were immunostained with β-catenin: 25 from duodenal adenomas and the remaining 14 had normal duodenal mucosa (n=11) or polypoid gastric duodenal metaplasia (n=3). Results: Eighteen out of the 25 duodenal adenomas (72%) showed β-catenin helices; in contrast, none of the 33 control biopsies (including those with normal duodenal mucosa, gastric duodenal metaplasia and normal mucosa adjacent to 19 adenomas) showed β-catenin helices (p<0.05). The review of diagnostic H&E-stained sections and of β-catenin-stained nuclei revealed that the dysplastic nuclei were arranged in a picket fence-like fashion along the basement membrane of the glands and not as loops within the dysplastic glands; the nuclei of the dysplastic glands were not forming part of the β-catenin helices. Discussion: If these β-catenin coils are unrelated to an abnormal nuclear distribution at the base of the dysplastic glands, the rational explanation might be that the helices highlight changes taking place in the cytoplasm of affected glandular cells. Conclusion: According to some authors, mutations in the β-catenin genes are always associated with a morphologically neoplastic course. It is herein proposed that β-catenin helices in duodenal adenomas might uncover a novel cytoplasmic phenomenon ensuing during the adenoma-carcinoma pathway.

  • Duodenum adenomas
  • adenomas
  • β-catenin
  • cytoplasmic helices

The histological examination of duodenal polyps may disclose adenomas (tubular, villous, tubulovillous or Brunner's gland adenomas), Peutz–Jeghers hamartomas, polypoid gastric metaplasia of the duodenum (GMD), inflammatory fibroids, carcinoids, lymphomas or mesenchymal tumors (lipoma, leiomyoma, leiomyoblastoma, vascular, fibroma, neurogenic or gangliocytic praganglioma) (1).

Duodenal adenomas are epithelial polyps with dysplastic glands built of mutated cells having proliferative, biochemical and molecular aberrations (2). Adenomas may evolve sporadically in the general population or through germline mutations as in familial adenomatous polyposis (FAP) (3).

The incidence of duodenal adenomas is 0.1% to 0.3% (4). The prevalence of sporadic duodenal adenomas in patients referred for upper gastrointestinal endoscopy is about 5% (5). On the other hand, 50% to ≥90% of FAP patients exhibit duodenal adenomas (6).

In later years, much research has been done to unveil the molecular aberrations evolving in duodenal adenomas. In these lesions, initiation and progression is triggered by deregulation of Wnt/β-catenin signaling (also referred to as canonical Wnt signaling) leading to increased transcriptional activity of the protein β-catenin (7). The Wnt pathway (the custodian of stem cell regulation (8)) is activated via the tumor suppressor APC (adenomatous polyposis coli) gene, resulting in loss of heterozygosity (LOH), inactivation and mutations of the APC protein complex targeting β-catenin (7, 9). The cytoplasmic β-catenin protein is constantly degraded and eliminated by the action of the Axin complex that prevents β-catenin from reaching the nucleus (10). In the absence of Wnt signal (off-state), β-catenin precludes phosphorylation of the glycogen synthase kinase 3 beta (GSK-3β) leading to aberrant nuclear accumulation (11). The nuclear accumulation of β-catenin elicits the transcriptional activation of the T-cell factors (TCFs) that regulate the genes involved in cell proliferation and apoptosis (12).

In FAP, the underlying genetic cause is the germline mutation of the APC gene located on 5q21; the transcription factor β-catenin is the key effector of the Wnt/β-catenin pathway. β-catenin is stabilized constitutively, providing a permanent mitogenic signal to normally-resting cells. This occurs when the second APC allele is somatically inactivated (7). In most duodenal adenomas, there is a decreased APC-associated degradation of β-catenin. In approximately one half of the remainder of tumors with wild-type APC, this is due to mutations in β-catenin itself (CTNNB1) (13).

Several studies have assessed the frequency of β-catenin immunostained nuclei in duodenal adenomas (14-16). While investigating the nuclear expression of β-catenin in immunostained duodenal biopsies, we observed a non-previously described phenomenon, namely the presence of activated β-catenin helices in the cytoplasm of the adenomatous glands.

The purpose of the present work was to report and illustrate this novel finding in duodenal adenomas from patients with FAP, as well as in sporadic cases.

Materials and Methods

Sections from 39 consecutive duodenal biopsies diagnosed by the senior author (CAR) were investigated: 25 adenomas, three polyps exhibiting chronic inflammation and gastric metaplasia (GMD) (17) and 11 with normal duodenal mucosa. In addition, normal duodenal mucosa adjacent to adenomas was present in 19 of the 25 adenomas.

Helices were regarded those β-catenin-positive coils, ringlets or whirls, that could be seen in single crypts or connecting two or more crypts.

Diagnostic sections were cut at 4 μm, stained with hematoxylin and eosin (H&E) and immunostained with anti β-catenin (Ready to use, Bond Reagents; Leica Biosystems AB, Kista, Sweden). β-catenin immunostained sections were scrutinized using a high power objective (×40).

Statistical analysis. The non-parametric Mann–Whitney test was used. Statistical significance was set at p<0.05.

Results

β-catenin in the normal duodenal mucosa and in GMD. None of the 33 biopsies with normal duodenal mucosa - including the normal mucosa adjacent to 19 adenomas- as well as three biopsies with GDM displayed β-catenin helices or β-catenin-activated nuclei (Table I).

Duodenal adenomas. All 25 duodenal adenomas were tubular adenomas with low-grade dysplasia: 72% (n=18) were FAP adenomas and the remaining 28% (n=7) sporadic adenomas.

β-catenin in duodenal adenomas.

  1. β-catenin cytoplasmic helices: β-catenin cytoplasmic helices were found in 72% (18/25): in 72.2% (13/18) of the FAP adenomas and in 71.4% (5/7) of the sporadic adenomas (Figures 1, 2 and 3 a).

  2. β-catenin activated nuclei: β-catenin-stained nuclei were found in 64% (16/25): in 66.7% (12/18) of the FAP adenomas and in 71.4% (5/7) of the sporadic adenomas (Figure 3 b).

The difference in β-catenin cytoplasmic helices and β-catenin-stained nuclei in FAP and sporadic adenomas vs. non-neoplastic duodenal mucosas (normal mucosa, GMD and the normal mucosa adjacent duodenal adenomas, was significant (p<0.05). No difference in the frequency of β-catenin cytoplasmic helices and of β-catenin-stained nuclei was found between FAP and sporadic duodenal adenomas.

Discussion

The search for β-catenin-stained nuclei in duodenal adenomas disclosed, unexpectedly, helices of β-catenin in the cytoplasm of a group of dysplastic glands in 72% of the duodenal adenomas investigated but in none of the specimens having polypoid GMD or normal duodenal mucosa (including the normal mucosa adjacent to duodenal adenomas). The review of diagnostic H&E-stained sections and of β-catenin-stained nuclei revealed that the dysplastic nuclei were arranged in a picket fence-like fashion along the basement membrane of the glands (Figure 3c) and not as loops within the dysplastic glands. Hence, nuclear disarrangement resembling helices was not found in H&E sections and in β-catenin immunostains implying that nuclei of the dysplastic glands were not participating in the β-catenin helices. If these β-catenin coils are unrelated to an abnormal nuclear distribution at the base of the dysplastic glands, the rational explanation might be that the helices highlight changes taking place in the cytoplasm of affected glandular cells.

Given the logistical difficulties and resources associated with direct sequencing of β-catenin (CTNNB1), most investigations have used immunohistochemistry with the assumption that the presence of stained nuclei is often associated with β-catenin mutation. Since β-catenin coils were not present in sections with GMD or with histologically-normal duodenal mucosa -not even in the normal mucosa adjacent to duodenal adenomas- the possibility that the β-catenin helices found in the adenomatous tissue could mirror a novel putative mutation in the cytoplasm of adenomatous glands could not be totally rejected. Assuming that all dysplastic cells in duodenal adenomas are mutated, the lack of β-catenin-positive nuclei in the remaining 36% of the adenomas appears to indicate that the immunostain used in the present work was not sensitive enough to detect mutated nuclei in all lesions. Perhaps the same applies for the lack of β-catenin-positive helices in 28% of the adenomas.

In light of the present results, we are prone to speculate that β-catenin helices in duodenal adenomas might highlight a cytoplasmic phenomenon ensuing during the adenoma-carcinoma pathway. It is at present unclear whether the cytoplasmic helices in these neoplasias occur already at the stem cell level (18) or following one or more mitoses in dysplastic cells (19). This puzzling phenomenon might be of significance considering that β-catenin plays a crucial role in the Wnt/β-catenin signaling pathway during cancer progression (20, 21). It has been postulated that mutations in the β-catenin genes are always associated with a morphologically neoplastic course (22).

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Two different tubular adenomas of the duodenum showing multiple β-catenin helices in the cytoplasm of dysplastic glandular cells (β-catenin immunostain, ×10).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table I.

The frequency of β-catenin-positive nuclei and of β-catenin-positive cytoplasmic helices in 25 duodenal adenomas and in 33 controls*.

It should be mentioned that similar cytoplasmic β-catenin helices were recently found in small sessile serrated adenoma/polyp (SSA/P) and conventional colorectal adenomas (23).

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Left panel: Tubular adenoma of the duodenum showing multiple β-catenin helices in the cytoplasm of dysplastic glandular cells (β-catenin immunostain, ×20). Right panel: Cloned image from the left panel to highlight the β-catenin helices using the INVERT function of a Photoshop Program (Ps Adobe Photoshop CS3 extended).

Figure 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3.

a: Another tubular adenoma of the duodenum showing multiple β-catenin helices in the cytoplasm of dysplastic glandular cells (β-catenin immunostain, ×10), b: Tubular adenoma of the duodenum showing multiple β-catenin-stained nuclei in dysplastic glandular cells (β-catenin immunostain, ×20), c: Tubular adenoma of the duodenum. Note the regular “picket-fence” nuclear disposition in the glands (H&E ×20).

Footnotes

  • Conflicts of Interest

    None.

  • Received December 1, 2014.
  • Revision received December 8, 2014.
  • Accepted December 11, 2014.
  • Copyright© 2015 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

References

  1. ↵
    1. Culver EL,
    2. McIntyre AS
    : Sporadic duodenal polyps: classification, investigation, and management. Endoscopy 43: 144-155, 2011.
    OpenUrlPubMed
  2. ↵
    1. Singh SR
    1. Rubio CA
    : Signaling pathways, gene regulation and duodenal neoplasias. In: Signaling, Gene Regulation and Cancer. Singh SR (ed.) Nova Science Publishers, Inc. Haupauge, NY, USA, Chapter 6, pp. 83-110, 2013.
  3. ↵
    1. Sharaiha RZ,
    2. Cohen MS,
    3. Reimers L,
    4. Khashab MA,
    5. Giardiello FM,
    6. Neugut AI
    : Sporadic duodenal adenoma and association with colorectal neoplasia: a case-control study. Dig Dis Sci 59: 2523-2528, 2014.
    OpenUrlPubMed
  4. ↵
    1. Jepsen JM,
    2. Persson M,
    3. Jakobsen NO,
    4. Christiansen T,
    5. Skoubo-Kristensen E,
    6. Funch-Jensen P,
    7. Kruse A,
    8. Thommesen P
    : Prospective study of prevalence and endoscopic and histopathologic characteristics of duodenal polyps in patients submitted to upper endoscopy. Scand J Gastroenterol 29: 483-448, 1994.
    OpenUrlPubMed
  5. ↵
    1. van Heumen BW,
    2. Mul K,
    3. Nagtegaal ID,
    4. van Kouwen MC,
    5. Nagengast FM
    : Management of sporadic duodenal adenomas and the association with colorectal neoplasms: a retrospective cohort study. J Clin Gastroenterol 46: 390-396, 2012.
    OpenUrlPubMed
  6. ↵
    1. Bülow S,
    2. Björk J,
    3. Christensen IJ,
    4. Fausa O,
    5. Järvinen H,
    6. Moesgaard F,
    7. Vasen HF,
    8. DAF Study Group
    : Duodenal adenomatosis in familial adenomatous polyposis. Gut 53: 381-388, 2004.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Kohler EM,
    2. Chandra SH,
    3. Behrens J,
    4. Schneikert J
    : Beta-catenin degradation mediated by the CID domain of APC provides a model for the selection of APC mutations in colorectal, desmoid and duodenal tumours. Hum Mol Genet 18: 213-226, 2009.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    1. Clevers H,
    2. Nusse R
    : Wnt/β-catenin signaling and disease. Cell 149: 1192-1205, 2012.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Zakharov V,
    2. Ren B,
    3. Ryan C,
    4. Cao W
    : Diagnostic value of HMGAs, p53 and β-catenin in discriminating adenocarcinoma from adenoma or reactive atypia in ampulla and common bile duct biopsies. Histopathology 62: 778-787, 2013.
    OpenUrlPubMed
  10. ↵
    1. Gutierrez-Gonzalez L,
    2. Deheragoda M,
    3. Elia G,
    4. Leedham SJ,
    5. Shankar A,
    6. Imber C,
    7. Jankowski JA,
    8. Turnbull DM,
    9. Novelli M,
    10. Wright NA,
    11. McDonald SA
    : Analysis of the clonal architecture of the human small intestinal epithelium establishes a common stem cell for all lineages and reveals a mechanism for the fixation and spread of mutations. J Pathol 217: 489-496, 2009.
    OpenUrlCrossRefPubMed
  11. ↵
    1. Korinek V,
    2. Barker N,
    3. Morin PJ,
    4. van Wichen D,
    5. de Weger R,
    6. Kinzler KW,
    7. Vogelstein B,
    8. Clevers H
    : Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC−/− colon carcinoma. Science 275: 1784-1787, 1997.
    OpenUrlAbstract/FREE Full Text
  12. ↵
    1. Jalving M,
    2. Heijink DM,
    3. Koornstra JJ,
    4. Boersma-van Ek W,
    5. Zwart N,
    6. Wesseling J,
    7. Sluiter WJ,
    8. de Vries EG,
    9. Kleibeuker JH,
    10. de Jong S
    : Regulation of TRAIL receptor expression by β-catenin in colorectal tumours. Carcinogenesis 35: 1092-1099, 2014.
    OpenUrlAbstract/FREE Full Text
  13. ↵
    1. Groves C,
    2. Lamlum H,
    3. Crabtree M,
    4. Williamson J,
    5. Taylor C,
    6. Bass S,
    7. Cuthbert-Heavens D,
    8. Hodgson S,
    9. Phillips R,
    10. Tomlinson T
    : Mutation cluster region, association between germline and somatic mutations and genotype-phenotype correlation in upper gastrointestinal familial adenomatous polyposis. Am J Pathol 160: 2055-2061, 2002.
    OpenUrlPubMed
  14. ↵
    1. Park S,
    2. Kim SW,
    3. Lee BL,
    4. Jung EJ,
    5. Kim WH
    : Expression of E-cadherin and beta-catenin in the adenoma-carcinoma sequence of ampulla of Vater cancer. Hepatogastroenterology 53: 28-32, 2006.
    OpenUrlPubMed
    1. Wagner PL,
    2. Chen YT,
    3. Yantiss RK
    : Immunohistochemical and molecular features of sporadic and FAP-associated duodenal adenomas of the ampullary and nonampullary mucosa. Am J Surg Pathol 32: 1388-1395, 2008.
    OpenUrlPubMed
  15. ↵
    1. Breuhahn K,
    2. Singh S,
    3. Schirmacher P,
    4. Bläker H
    : Large-scale N-terminal deletions but not point mutations stabilize beta-catenin in small bowel carcinomas, suggesting divergent molecular pathways of small and large intestinal carcinogenesis. J Pathol 215: 300-307, 2008.
    OpenUrlPubMed
  16. ↵
    1. Rubio CA
    : Gastric duodenal metaplasia in duodenal adenomas. J Clin Pathol 60: 661-663, 2007.
    OpenUrlAbstract/FREE Full Text
  17. ↵
    1. Rubio CA
    : Stem cells might participate in the cell turnover of duodenal adenomas. Int J Clin Exp Pathol 2: 149-153, 2009.
    OpenUrlPubMed
  18. ↵
    1. Singh SR
    1. Rubio CA
    : Putative Stem Cells in Mucosas of the Esophago-Gastrointestinal Tract. Chapter 10. In: Stem Cell, Regenerative Medicine and Cancer. Singh SR (ed.) Nova Science Publishers, Inc. Haupauge, NY, USA pp. 279-308, 2011.
  19. ↵
    1. Ha NC,
    2. Tonozuka T,
    3. Stamos JL,
    4. Choi HJ,
    5. Weis WI
    : Mechanism of phosphorylation-dependent binding of APC to beta-catenin and its role in beta-catenin degradation. Mol Cell 15: 511-521, 2004.
    OpenUrlCrossRefPubMed
  20. ↵
    1. Wang J,
    2. Wang X,
    3. Gong W,
    4. Mi B,
    5. Liu S,
    6. Jiang B
    : Increased expression of beta-catenin, phosphorylated glycogen synthase kinase 3beta, cyclin D1, and c-myc in laterally spreading colorectal tumors. J Histochem Cytochem 57: 363-371, 2009.
    OpenUrlAbstract/FREE Full Text
  21. ↵
    1. Hassan A,
    2. Yerian LM,
    3. Kuan SF,
    4. Xiao SY,
    5. Hart J,
    6. Wang HL
    : Immunohistochemical evaluation of adenomatous polyposis coli, beta-catenin, c-Myc, cyclin D1, p53, and retinoblastoma protein expression in syndromic and sporadic fundic gland polyps. Hum Pathol 35: 328-334, 2004.
    OpenUrlCrossRefPubMed
  22. ↵
    1. Rubio CA,
    2. Kaufeldt A,
    3. Koha R,
    4. Ushoida M,
    5. Lindahl J,
    6. Kis LL
    : β-Catenin Helices in the Cytoplasm of Sessile Serrated Adenoma/Polyps and Conventional Colorectal Adenomas. Anticancer Res 35: 929-934, 2015.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

Anticancer Research: 35 (3)
Anticancer Research
Vol. 35, Issue 3
March 2015
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
β-catenin Helices in the Cytoplasm of Sporadic and FAP Duodenal Adenomas
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
4 + 3 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
β-catenin Helices in the Cytoplasm of Sporadic and FAP Duodenal Adenomas
CARLOS A. RUBIO, ANN KAUFELDT, RAFAT KOHAN, MARIKO USHOIDA, ERIKA EZELIUS, SAN BJÖRK, JENNY LINDAHL
Anticancer Research Mar 2015, 35 (3) 1433-1436;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
β-catenin Helices in the Cytoplasm of Sporadic and FAP Duodenal Adenomas
CARLOS A. RUBIO, ANN KAUFELDT, RAFAT KOHAN, MARIKO USHOIDA, ERIKA EZELIUS, SAN BJÖRK, JENNY LINDAHL
Anticancer Research Mar 2015, 35 (3) 1433-1436;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • 5-Azacytidine (5-aza) Induces p53-associated Cell Death Through Inhibition of DNA Methyltransferase Activity in Hep3B and HT-29 Cells
  • Prognostic Value of WNT1, NOTCH1, PDGFRβ, and CXCR4 in Oral Squamous Cell Carcinoma
  • Hypoxia-adapted Multiple Myeloma Stem Cells Resist γδ-T-Cell-mediated Killing by Modulating the Mevalonate Pathway
Show more Experimental Studies

Similar Articles

Keywords

  • Duodenum adenomas
  • adenomas
  • β-catenin
  • cytoplasmic helices
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire